1. Home
  2. CBIO vs VFF Comparison

CBIO vs VFF Comparison

Compare CBIO & VFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CBIO

Crescent Biopharma Inc.

HOLD

Current Price

$10.83

Market Cap

389.7M

Sector

N/A

ML Signal

HOLD

Logo Village Farms International Inc.

VFF

Village Farms International Inc.

HOLD

Current Price

$3.41

Market Cap

396.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBIO
VFF
Founded
2003
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
389.7M
396.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CBIO
VFF
Price
$10.83
$3.41
Analyst Decision
Strong Buy
Buy
Analyst Count
6
1
Target Price
$27.17
N/A
AVG Volume (30 Days)
142.5K
1.1M
Earning Date
02-23-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.19
Revenue
N/A
$351,979,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.43
P/E Ratio
N/A
$17.89
Revenue Growth
N/A
56.61
52 Week Low
$9.81
$0.45
52 Week High
$21.40
$4.99

Technical Indicators

Market Signals
Indicator
CBIO
VFF
Relative Strength Index (RSI) 37.86 43.80
Support Level $10.56 $3.25
Resistance Level $14.71 $3.65
Average True Range (ATR) 1.01 0.17
MACD -0.07 -0.01
Stochastic Oscillator 6.14 38.75

Price Performance

Historical Comparison
CBIO
VFF

About CBIO Crescent Biopharma Inc.

Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody. Crescent believes CR-001 has the potential to deliver improved clinical efficacy and safety over pembrolizumab. CR-001 is a new molecular entity designed to replicate the functional properties of ivonescimab, a cooperative bispecific anti-PD-1/anti-VEGF antibody in development by Akeso Biopharma and Summit Therapeutics that delivered improved efficacy in a head-to-head Phase 3 clinical trial versus Keytruda in non-small cell lung cancer. Crescent is advancing its second and third programs, CR-002 and CR-003, which are antibody drug conjugates (ADCs) against validated oncology targets.

About VFF Village Farms International Inc.

Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Leli . The company makes majority of its revenue from the Produce segment.

Share on Social Networks: